The COLOSSUS Project
Colorectal cancer is the third most common cancer in Europe. COLOSSUS is an EU-funded H2020 project that aims to provide new and more effective ways to classify patients with a specific type of colorectal cancer (microsatellite stable RAS mutant metastatic colorectal cancer or MSS RAS mt mCRC) and to develop better treatments for them. Our ultimate goal is to deliver a personalised medicine approach for patients with MSS RAS mt mCRC that is currently not available.
Project Partners
The COLOSSUS Project brings together a multidisciplinary team of 13 different partners from 7 different countries.
Latest News
COLOSSUS publication in Bioinformatics from UNITO
Our partners at the University of Torino announce the publication of a COLOSSUS-acknowledged paper in the journal Bioinformatics in May 2023. The paper is titled: CONNECTOR, fitting and clustering of longitudinal data to reveal a [...]
Dr Anguraj Sadanandam, ICR publishes breakthrough pancreatic cancer paper in Nature
COLOSSUS PI Dr Sadanandam, of The Institute of Cancer Research, London is the co-senior author of a breakthrough pancreatic cancer study. The co-senior author is Costas Lyssiotis at the University of Michigan. The open-access paper, [...]
Two new COLOSSUS publications from Prof. Livio Trusolino’s group
Congratulations to our partners at the Universita degli Studi di Torino and their collaborators for two recent COLOSSUS-acknowledged publications! The first was a review titled "Towards precision oncology with patient-derived xenografts" which was published in [...]